AADAC Antikörper (AA 301-350)

Produktnummer ABIN205073

Produktdetails anti-AADAC Antikörper

Target: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Bindungsspezifität: AA 301-350

Reaktivität: Human, Pferd

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser AADAC Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Human AADAC

Homologie: Percent identity by BLAST analysis: Dog (92%) Horse (85%).

Aufreinigung: Protein A purified

Immunogen: Synthetic peptide located between aa301-350 of human AADAC (P22760, NP_001077). Percent identity by BLAST analysis: Human, Chimpanzee, Panda (100%), Gorilla, Marmoset, Dog, Bovine, Lizard (92%), Elephant, Horse (85%).

Type of Immunogen: Synthetic peptide

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: WB (2.5 μg/mL)

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: After adding water, will consist of PBS buffer with 2 % sucrose

Konzentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Details zu AADAC

Target: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Andere Bezeichnung: AADAC (AADAC Produkte)

Hintergrund: Name/Gene ID: AADAC

Synonyms: AADAC, CES5A1, DAC, Arylacetamide deacetylase

Gen-ID: 13

NCBI Accession: NP_001077

UniProt: P22760